ABAK's Website Loading

About Us

LEARN MORE

ABOUT OUR ASSOCIATION

Alcoholic Beverages Association of Kenya (ABAK) is an umbrella body that brings
together Kenya’s leading manufacturers and distributors of alcoholic beverages for
adults.

ABAK exists to support the alcohol industry by providing training, information and technical expertise to the government agencies, consumers, value chain players and the society, at large.

A non-profit organisation, ABAK was founded in 2007.It was then known as the National Alcoholic Beverages Association of Kenya (NABAK). Initially, the aim was to bring together industry players to champion and adopt a common position while addressing a myriad of challenges faced by the industry such as the rise of illicit alcoholic drinks produced by unscrupulous individuals.

ABAK is headed by a board of directors comprising of Chief Executives from member companies. A Management Committee comprising of Senior Managers from these organisations is responsible for the day-to-day running of the association with the help of a permanent secretariat.

get in touch now!

Our Mission

mission

Avoid losses that arise from the production and sale of illicit and illegal brews Act as a catalyst for maximising value from government, consumers, value chain players and the society Creating an enabling environment for stakeholders.

Our Vision

vision-320x240

To promote the role of the alcohol industry as a trusted partner to the government, consumers, value chain players and society towards responsible, safe and controlled consumption of alcohol.

MEET OUR MANAGEMENT COMMITTEE

Eric Githua

Chairman

Corporate and Regulatory Affairs,  Kenya Wine Agencies Ltd

Ps Mann

Vice Chairman

Managing Director, London Distillers

Eric Kiniti

Secretary

Corporate Affairs Director, EABL

William Kamau

Treasurer 

Operations Manager, FRM EA Packers.

Get Our Company Profile...

Download now!

OUR VISION

To promote the role of the alcohol industry as a trusted partner to the government, consumers, value chain players and society towards responsible, safe and controlled consumption of alcohol.

減肥藥台灣購物

2009年8月FDA針對服用120毫克Orlistat及60毫克非處方藥Orlistat,進行全面審查及檢討,結果確定共有13例嚴重肝損傷個案,減肥藥,必須在其標籤加註,有12人服用120毫克Orlistat,1人服用60毫克Orlistat,而13例中,有2例死於肝衰竭,共3例需要肝臟移植手術。